OPKO Health Inc (OPK) - Medical Equipment - Deals and Alliances Profile

OPKO Health Inc (OPK) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME41384D
  • |
  • Pages: 60
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company's product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers its diagonostics and therapeutics that are used in the treatment of chronic kidney disease, obesity, asthma, chronic obstructive pulmonary disease (COPD), cancer and chemotherapy-induced nausea and vomiting, among others. It also offers neutraceuticals and veterinary products.The company also offers contract research services to other pharmaceutical companies. The company has its operational presence with its offices located in Chile, Mexico, Spain, Ireland, Canada and Israel. OPKO is headquartered in Miami, Florida, the US.

OPKO Health Inc (OPK)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

OPKO Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OPKO Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

OPKO Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OPKO Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

OPKO Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

OPKO Health Inc, Medical Equipment, Deal Details 12

Venture Financing 12

InCellDx Raises USD 4 Million In Venture Financing 12

Partnerships 13

Opko Health Enters Into Licensing Agreement With International Health Technology For Prostate Cancer Biomarker Panel 13

LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 14

OPKO Health Enters Into Licensing Agreement With Arctic Partners For Biomakers 15

GeneDx Enters into Research Agreement with Radboud University 16

North Shore-LIJ Health System and OPKO Health Enter into Partnership 17

Opko Health Expands Co-Development Agreement With Bristol-Myers Squibb For Alzheimer's Biomarkers 18

Bio-Reference Labs Enters Into Licensing Agreement With University of Washington 19

Genetic Technologies Enters Into Licensing Agreement With Bio-Reference Labs 20

OPKO Health Enters Into Licensing Agreement With BioZone Pharma For Drug Delivery Platforms 21

Equity Offering 22

Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 22

Arno Therapeutics Completes Private Placement Of Units For USD 30.7 Million 24

Neovasc Completes Private Placement Of Shares For USD 2.2 Million Upon Exercise Of Warrants 26

Debt Offering 27

OPKO Health Raises USD55 Million in Public Offering of 5% Notes Due 2023 27

Opko Health Completes Private Placement Of Notes Due 2033 For USD 175 Million 28

Acquisition 30

Opko Health Acquires Bio-Reference Labs 30

Opko Health Acquires Inspiro Medical 32

Opko Health Completes Acquisition Of Laboratorio Arama 33

BioReference Labs To Acquire Edge Bioserv From Edge BioSystems 34

Opko Health Completes Acquisition Of Silcon Comercio 35

OPKO Health Inc-Key Competitors 36

OPKO Health Inc-Key Employees 37

OPKO Health Inc-Locations And Subsidiaries 38

Head Office 38

Other Locations & Subsidiaries 38

Recent Developments 41

Strategy And Business Planning 41

Sep 19, 2017: OPKO's BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care 41

Financial Announcements 42

Aug 07, 2018: Opko Health announces second quarter 2018 financial results 42

May 08, 2018: OPKO Health Announces First Quarter 2018 Financial Results 43

Mar 01, 2018: OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results 45

Nov 08, 2017: OPKO Health Reports 2017 Third Quarter Highlights and Financial Results 47

Aug 08, 2017: OPKO Health Reports Second Quarter 2017 Business and Financial Results 48

May 09, 2017: OPKO Health Reports 2016 Financial and Operating Results 50

Mar 01, 2017: OPKO Health Reports 2016 Financial and Operating Results 51

Corporate Communications 53

May 01, 2018: OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories 53

Jan 26, 2018: OPKO Health Announces Resignation Of Gregory Henderson As President Of BioReference Laboratories 54

Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories 55

Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories 56

Mar 03, 2017: OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development 57

Product News 58

Sep 12, 2017: OPKO's GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings 58

Other Significant Developments 59

Feb 28, 2017: OPKO Health's GeneDx Announces Participation in Illumina's iHope Program on International Rare Disease Day 59

Appendix 60

Methodology 60

About GlobalData 60

Contact Us 60

Disclaimer 60

List of Figures

OPKO Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

OPKO Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

OPKO Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

OPKO Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

OPKO Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OPKO Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

OPKO Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OPKO Health Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

List of Tables

OPKO Health Inc, Medical Equipment, Key Facts, 2017 2

OPKO Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

OPKO Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

OPKO Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

OPKO Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

OPKO Health Inc, Deals By Market, 2012 to YTD 2018 9

OPKO Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

InCellDx Raises USD 4 Million In Venture Financing 12

Opko Health Enters Into Licensing Agreement With International Health Technology For Prostate Cancer Biomarker Panel 13

LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 14

OPKO Health Enters Into Licensing Agreement With Arctic Partners For Biomakers 15

GeneDx Enters into Research Agreement with Radboud University 16

North Shore-LIJ Health System and OPKO Health Enter into Partnership 17

Opko Health Expands Co-Development Agreement With Bristol-Myers Squibb For Alzheimer's Biomarkers 18

Bio-Reference Labs Enters Into Licensing Agreement With University of Washington 19

Genetic Technologies Enters Into Licensing Agreement With Bio-Reference Labs 20

OPKO Health Enters Into Licensing Agreement With BioZone Pharma For Drug Delivery Platforms 21

Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 22

Arno Therapeutics Completes Private Placement Of Units For USD 30.7 Million 24

Neovasc Completes Private Placement Of Shares For USD 2.2 Million Upon Exercise Of Warrants 26

OPKO Health Raises USD55 Million in Public Offering of 5% Notes Due 2023 27

Opko Health Completes Private Placement Of Notes Due 2033 For USD 175 Million 28

Opko Health Acquires Bio-Reference Labs 30

Opko Health Acquires Inspiro Medical 32

Opko Health Completes Acquisition Of Laboratorio Arama 33

BioReference Labs To Acquire Edge Bioserv From Edge BioSystems 34

Opko Health Completes Acquisition Of Silcon Comercio 35

OPKO Health Inc, Key Competitors 36

OPKO Health Inc, Key Employees 37

OPKO Health Inc, Other Locations 38

OPKO Health Inc, Subsidiaries 38

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

OPKO Health Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17840
Site License
USD 500 INR 35680
Corporate User License
USD 750 INR 53520

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com